Pharma BD Deal Intelligence

Valeant Pharmaceuticals International, Inc. / Sanitas Group AB

2011 · Acquisition/Merger · $440M · Complete

Announcement Sentiment

75

Strongly positive

Valeant acquired 87.2% of Lithuanian/CEE pharma group Sanitas for €314M (~$440M).

Did it work? Outcome assessment

Strategic verdict

Partially Achieved

Assessment window: 5yr post-close.

Key facts

Announced Aug 22, 2011
Closed Aug 22, 2011
Deal value $440M
Deal type Acquisition/Merger
Therapeutic area Generics, OTC, primary care
Indications Generics, OTC, primary care
Key assets Central/Eastern European generics and OTC portfolio
Mechanism Generic small-molecule pharmaceuticals

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals